BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg Upregulation
Sena Kim(Seoul National University), Jaebok Choi(Washington University in St. Louis)
Cited by 0
Related Papers
In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
|Blood|2010|306
Endoplasmic Reticulum Stress–Induced IRE1α Activation Mediates Cross-Talk of GSK-3β and XBP-1 To Regulate Inflammatory Cytokine Production
|The Journal of Immunology|2015|136